...
 Why us?  Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

 Author  Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making. Authored and medically reviewed by Dr Farzana Khan.

MD MRCGP DFFP
Was this answer helpful?
Rate Dr Farzana's explanation
faq Vaginal Laxity (postnatalmenopause support)

Do I need a gap between different treatment types?

Yes—building in short gaps helps tissues recover and lets you judge what actually works. As a guide: separate energy-based sessions (laser or radiofrequency) by 4–8 weeks; allow 1–2 weeks after an injectable (PRP, polynucleotides, superficial HA boosters) before high-friction activities; and avoid stacking multiple new procedures on the same day. Keep pelvic floor rehab and GSM care running throughout. Educational only. Results vary. Not a cure.

Clinical Context

Who benefits most from planned gaps? Postnatal or peri-/post-menopausal women with mild, entry-focused symptoms who are layering care after excellent foundations. Spacing helps tissues settle and makes outcomes clearer.

Who should wait longer? Anyone with active BV/thrush/UTI, fever or foul discharge, new post-menopausal bleeding, recent pelvic/perineal surgery without clearance, suspected prolapse beyond the introitus, or pain-dominant presentations. Address safety and diagnosis first.

Next steps now. Keep PFMT and GSM care continuous; use a simple diary (sting scores, micro-tears, air-trapping episodes, tampon stability, ease at first penetration). Add only one new step at a time and reassess at 6–12 weeks before considering another layer.

Evidence-Based Approaches

NHS (patient-friendly foundations): Practical guides for conservative care underpin all pathways: NHS – pelvic floor exercises.

NICE urinary incontinence & prolapse (NG123): Recommends supervised pelvic floor muscle training first line with criteria for escalation—supporting a stepwise, spaced approach rather than stacking procedures. NICE NG123.

NICE menopause guideline (NG23): Emphasises moisturisers/lubricants and considering low-dose local vaginal oestrogen when symptoms affect quality of life; procedures are not first-line for GSM, reinforcing conservative foundations. NICE NG23.

Cochrane Library (energy-based therapies): Systematic reviews of vaginal laser/RF highlight small trials, short follow-up and heterogeneous protocols—hence cautious, audit-backed use with adequate spacing and review. Cochrane – vaginal laser/RF.

MHRA (UK regulator): Guidance on medical devices, intended use and vigilance supports safe scheduling and monitoring when planning any intimate device pathway. MHRA – medical devices.